Designing a New Molecular Probe: The Potential Role for Tilmanocept (Lymphoseek®) in the Assessment of Patients with Painful Hip and Knee Joint Prostheses

O.O. Adesanya1, *, C.E. Hutchinson1
1 Radiology department UHCW, Clifford Bridge Road. Coventry CV2 2DX, United Kingdom

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 938
Abstract HTML Views: 420
PDF Downloads: 287
ePub Downloads: 213
Total Views/Downloads: 1858
Unique Statistics:

Full-Text HTML Views: 636
Abstract HTML Views: 300
PDF Downloads: 220
ePub Downloads: 175
Total Views/Downloads: 1331

Creative Commons License
© 2017 Adesanya and Hutchinson

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Radiology department UHCW, Clifford Bridge Road. Coventry CV2 2DX, United Kingdom, Tel: 02476 964000; Fax: 02476967070; Email:



There is a long history of nuclear medicine developments in orthopaedics beginning in the early 20th century. Technetium-99m (99mTc) has a short half-life of six hours, emits 140 keV gamma rays and is the most widely used isotope, imaged with the Anger (gamma) camera. Gamma image quality and test sensitivity in painful prosthetic joints can be improved with single photon emission computed tomography (SPECT) and SPECT/CT. Positron Emission Tomography-Computed Tomography (PET-CT) with Sodium Fluoride (18F-NaF) and 18Fluorine-fluorodeoxyglucose (18F-FDG) PET have promising and limited roles respectively in the investigation of painful prosthetic joints. New SPECT/CT and PET-CT isotopes targeting activated macrophages with 99mTc Tilmanocept (Lymphoseek®) and 68Gallium labelled Tilmanocept respectively show potential as agents to demonstrate wear particles ingested by macrophages and multinucleated giant cells. An imaging algorithm using SPECT and/or PET agents is proffered as a cost effective way of speedily and accurately arriving a diagnosis.


Review of the historical role of nuclear medicine in orthopaedics and research into the potential role of new radiopharmaceutical agents was undertaken. Guidelines and algorithms for the imaging of complicated joint prosthesis are provided.


There is an established role for nuclear medicine in orthopaedics and particularly in the investigation of complicated joint prostheses. Imaging with Tilmanocept provides new opportunities to shorten the time to diagnose loosened and infected joint prostheses.


There is a potential new role for Tilmanocept, which can be utilised with both PET-CT and SPECT-CT technologies. Tilmanocept is a relatively new radiopharmaceutical which has a potential role in the imaging assessment of painful joint prosthesis.

Keywords: Joint prosthesis, Septic loosening, Aseptic loosening, Galium-68 Tilmanocept, PET-CT, SPECT-CT.